Exome screening and directed breeding of rhesus for human genetic disease models
Exome screening and directed breeding of rhesus for human genetic disease models
批准号:
9111085
负责人:
R. PAUL JOHNSON
金额:
$24.79万
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-08-01 至 2018-07-31
关键词:
ABCB1 geneAffectAnimal ModelAnimalsBreedingCYP21A2 geneCatalogingCatalogsDataDevelopmentDideoxy Chain Termination DNA SequencingDiseaseDisease modelEmbryoExhibitsFemaleFundingGene MutationGenesGeneticGenetic PolymorphismGenetic ScreeningGenomeGenotypeGoalsHealthHereditary DiseaseHeterozygoteHumanHuman GeneticsInstitutesInstitutionMacaca mulattaMarylandMendelian disorderMethodsModelingMonkeysMusMutationOrthologous GenePhenotypePhysiologyPopulationPre-Clinical ModelPrimatesProteinsResearchSystemUniversitiesValidationanimal breedingbasecostdisease phenotypedrug developmentexomeexome sequencingexpectationhuman diseaseloss of functionloss of function mutationmalemutantnonhuman primateoffspringpre-clinical researchscreeningtherapy developmenttranslational studytreatment strategy
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): There are over 6000 disorders in humans that result from a single gene mutation (Rappaport et al. 2013). For many of these conditions, there is no suitable animal model. Because rhesus macaques are genetically and physiologically similar to humans, they have the potential to offer preclinical models for numerous human conditions. We have preliminary data demonstrating that we can identify loss-of-function mutations in rhesus macaques related to human disease from exome sequencing, validate these results with PCR and Sanger sequencing and establish loss-of-function at the protein level. The overall goal of this proposal is to produce rhesus macaque models of single gene human genetic disorders. To accomplish this, we will identify naturally occurring loss-of-function mutations in rhesus macaques at the Yerkes National Primate Research Center (YNPRC). We already have exome sequence data from 61 animals. We will identify loss- of-function mutations in genes using the GATK pipeline and then validate these mutations with PCR/Sanger sequencing. Because these mutations are likely to be present in the heterozygous state, we propose to genotype 500 breeding rhesus macaques for a subset of the newly identified loci. The loci we choose to genotype will be based on whether the polymorphism leads to a predicted loss of function within genes implicated in human disease. After genotyping and identification of a sufficient number of animals that have the same mutation, we will breed multiple male and female heterozygotes with the expectation that 25% of the resulting offspring will be homozygous for the mutation. We expect that these animals will exhibit a phenotype similar to humans with loss-of-function mutations in the orthologous gene and serve as models for preclinical translational studies to begin to identify possible treatment strategies. When completed, this proposal will produce three distinct deliverables. 1) A catalog of high impact polymorphism present within a subset of the Yerkes rhesus population. 2) "Proof of concept" in an affected offspring that will serve as a model in the study of human single gene disorders. 3) Development of a pipeline to produce additional rhesus models of human genetic disease at Yerkes and other institutions.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1021/acs.chemrestox.6b00228
发表时间:
2016-09-19
期刊:
CHEMICAL RESEARCH IN TOXICOLOGY
影响因子:
4.1
作者:
[Lockridge, Oksana, Norgren, Robert B., Jr., Johnson, Rudolph C., Blake, Thomas A.]
通讯作者:
Blake, Thomas A.
Annual Symposium on Nonhuman Primates
-
批准号:10676977
-
项目类别:
-
资助金额:$7.5万
-
财政年份:2022
-
负责人:R. PAUL JOHNSON
-
依托单位:
Annual Symposium on Nonhuman Primates
-
批准号:10554035
-
项目类别:
-
资助金额:$7.5万
-
财政年份:2022
-
负责人:R. PAUL JOHNSON
-
依托单位:
Exome screening and directed breeding of rhesus for human genetic disease models
-
批准号:8970022
-
项目类别:
-
资助金额:$21.6万
-
财政年份:2015
-
负责人:R. PAUL JOHNSON
-
依托单位:
MODULATION OF PD-1 EXPRESSION ON T CELLS IN SIV-INFECTED MACAQUES
-
批准号:8357947
-
项目类别:
-
资助金额:$19.54万
-
财政年份:2011
-
负责人:R. PAUL JOHNSON
-
依托单位:
IMMUNOLOGICAL REAGENT AND SAMPLE DISTRIBUTION
-
批准号:8357913
-
项目类别:
-
资助金额:$19.54万
-
财政年份:2011
-
负责人:R. PAUL JOHNSON
-
依托单位:
DELINEATION OF MULTIPLE SUBPOPULATIONS OF NATURAL KILLER CELLS IN MONKEYS
-
批准号:8357919
-
项目类别:
-
资助金额:$19.39万
-
财政年份:2011
-
负责人:R. PAUL JOHNSON
-
依托单位:
Immunology
-
批准号:8198155
-
项目类别:
-
资助金额:$36.47万
-
财政年份:2011
-
负责人:R. PAUL JOHNSON
-
依托单位:
Live Attenuated SIV-Mediated Protection Against Mucosal SIV Infection
-
批准号:8198148
-
项目类别:
-
资助金额:$60.16万
-
财政年份:2011
-
负责人:R. PAUL JOHNSON
-
依托单位:
SURVIVAL OF THE FITTEST: CHALLENGING TRANSDUCED CELLS WITH HIV-1 REPLICATION
-
批准号:8357948
-
项目类别:
-
资助金额:$19.54万
-
财政年份:2011
-
负责人:R. PAUL JOHNSON
-
依托单位:
MODULATION OF PD-1 EXPRESSION ON T CELLS IN SIV-INFECTED MACAQUES
-
批准号:8172859
-
项目类别:
-
资助金额:$20.24万
-
财政年份:2010
-
负责人:R. PAUL JOHNSON
-
依托单位:
Construction of a Dual Function Primate Facility: ABSL3 and Transplant Medicine
-
批准号:7877509
-
项目类别:
-
资助金额:$1486.82万
-
财政年份:2010
-
负责人:R. PAUL JOHNSON
-
依托单位:
DELINEATION OF MULTIPLE SUBPOPULATIONS OF NATURAL KILLER CELLS IN MONKEYS
-
批准号:8172823
-
项目类别:
-
资助金额:$20.24万
-
财政年份:2010
-
负责人:R. PAUL JOHNSON
-
依托单位:
Natural killer cells and control of SIV infection
-
批准号:8085795
-
项目类别:
-
资助金额:$73.36万
-
财政年份:2010
-
负责人:R. PAUL JOHNSON
-
依托单位:
Natural killer cells and control of SIV infection
-
批准号:8292099
-
项目类别:
-
资助金额:$75.6万
-
财政年份:2010
-
负责人:R. PAUL JOHNSON
-
依托单位:
IMMUNOLOGICAL REAGENT AND SAMPLE DISTRIBUTION
-
批准号:8172817
-
项目类别:
-
资助金额:$20.24万
-
财政年份:2010
-
负责人:R. PAUL JOHNSON
-
依托单位:
Mechanisms of protective immunity induced by live attenuated SIV vaccines
-
批准号:8064463
-
项目类别:
-
资助金额:$19.75万
-
财政年份:2010
-
负责人:R. PAUL JOHNSON
-
依托单位:
Natural killer cells and control of SIV infection
-
批准号:8467672
-
项目类别:
-
资助金额:$71.07万
-
财政年份:2010
-
负责人:R. PAUL JOHNSON
-
依托单位:
CD8+ T CELLS AND PROTECTION AGAINST VAGINAL CHALLENGE INDUCED BY SIVMAC239DELTA3
-
批准号:8172858
-
项目类别:
-
资助金额:$20.24万
-
财政年份:2010
-
负责人:R. PAUL JOHNSON
-
依托单位:
Natural killer cells and control of SIV infection
-
批准号:7988488
-
项目类别:
-
资助金额:$79.47万
-
财政年份:2010
-
负责人:R. PAUL JOHNSON
-
依托单位:
SURVIVAL OF THE FITTEST: CHALLENGING TRANSDUCED CELLS WITH HIV-1 REPLICATION
-
批准号:8172860
-
项目类别:
-
资助金额:$20.24万
-
财政年份:2010
-
负责人:R. PAUL JOHNSON
-
依托单位:
海外基金